Back to News
Market Impact: 0.35

Guru Fundamental Report for COST

COSTGOOGLGOOGNDAQ
Company FundamentalsAnalyst InsightsCorporate EarningsCapital Returns (Dividends / Buybacks)Consumer Demand & RetailInvestor Sentiment & Positioning
Guru Fundamental Report for COST

Validea's 'Patient Investor' model, based on Warren Buffett's strategy, rates Costco Wholesale Corp (COST) at 79%, just below the 80% threshold indicating 'some interest' for the strategy. The large-cap retail stock demonstrates strong fundamentals, passing criteria for earnings predictability, debt service, return on equity, free cash flow, and expected return, but failed the 'Initial Rate of Return' test. This assessment highlights COST's long-term profitability and low debt, aligning with the model's focus on reasonably valued firms.

Analysis

Costco Wholesale Corp (COST) has received a 79% rating from Validea's "Patient Investor" model, which is based on Warren Buffett's investment strategy, placing it just below the 80% threshold for "some interest." This assessment underscores COST's robust underlying fundamentals, as evidenced by its passing grades in key areas such as earnings predictability, debt service, return on equity, free cash flow, and share repurchase. These strong metrics align with the model's emphasis on long-term, predictable profitability and a low debt profile. Despite these fundamental strengths, COST failed the "Initial Rate of Return" test, suggesting that its current valuation may not offer an immediately compelling entry point for investors strictly adhering to this value-oriented methodology. As a large-cap growth stock in the Retail (Specialty) sector, its premium valuation could be a contributing factor to this specific criterion. The overall sentiment surrounding COST in this analysis is strongly positive (0.75), reflecting its solid operational performance. The nuanced rating implies that while COST exhibits many characteristics of a high-quality business sought by long-term investors, its current market price might temper the expected near-term return potential for a strict value investor. This indicates a strong business with a potentially less compelling valuation from a pure "Patient Investor" perspective.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.